SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-21-016267
Filing Date
2021-01-25
Accepted
2021-01-25 16:28:01
Documents
2
Effectiveness Date
2021-01-25

Document Format Files

Seq Description Document Type Size
1 S-8 POS d109315ds8pos.htm S-8 POS 63016
2 EX-23.3 d109315dex233.htm EX-23.3 1962
  Complete submission text file 0001193125-21-016267.txt   66144
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-251033 | Film No.: 21549906
SIC: 2834 Pharmaceutical Preparations